MaxCyte, Inc. Announces a Business & Technical Update at Biotech Showcase 2013
Published: Jan 04, 2013
MaxCyte, Inc., the pioneer in scalable, high performance transient transfection systems, announces that Mr. Douglas Doerfler, President & CEO of MaxCyte, will present a business and technical update during Biotech Showcase 2013 to be held at the Parc 55 Wyndham San Francisco - Union Square in San Francisco, CA. Mr. Doerfler will speak on Tuesday, January 8, 2013, at 10:00 AM PST, in Track B held in Room Mission I. MaxCyte management will be available during the conference for detailed discussions in one-on-one meetings.